Novel motif:98: Difference between revisions
From FANTOM5_SSTAR
No edit summary |
No edit summary |
||
Line 1: | Line 1: | ||
{ | |||
Latest revision as of 15:03, 9 September 2013
name: | motif98_GCCGAAGATT |
---|
Association to promoter expression in human samples<b>Summary:</b>Significance of the correlation with CAGE expression, human <br><b>Analyst:</b> Michiel de Hoon<br><br>link to source dataset <br>data
Association to promoter expression in mouse samples
<b>Summary:</b>Significance of the correlation with CAGE expression, mouse <br><b>Analyst:</b> Michiel de Hoon<br><br>link to source dataset <br>data
GREAT analysis results for human
<b>Summary:</b>Genomic Enrichment of Annotations Tool (GREAT, Nat Biotechnol. 2010 May;28(5):495-501) is used to identify, both in human and in mouse, the gene ontology terms of biological processes enriched given the predicted TFBSs, and evaluated the overlap in the top-500 gene ontology terms between human and mouse. For each novel motif, the P value for the overlap was then evaluated by calculating its relative rank with respect to this background distribution.<br>Analyst: Michiel de Hoon<br><br>link to source dataset <br>data
GO ID | GO Term | p-value |
---|---|---|
GO:0035356 | cellular triglyceride homeostasis | 1.171039e-15 |
GO:0034389 | lipid particle organization | 1.485994e-14 |
GO:0021603 | cranial nerve formation | 3.723932e-13 |
GO:0048532 | anatomical structure arrangement | 1.379687e-12 |
GO:0010890 | positive regulation of sequestering of triglyceride | 5.084142e-12 |
GO:0006481 | C-terminal protein methylation | 1.461344e-10 |
GO:0010390 | histone monoubiquitination | 8.280360e-10 |
GO:0006513 | protein monoubiquitination | 1.975922e-9 |
GO:0002344 | B cell affinity maturation | 5.481432e-9 |
GO:0034725 | DNA replication-dependent nucleosome disassembly | 5.481432e-9 |
GO:0021783 | preganglionic parasympathetic nervous system development | 5.491686e-9 |
GO:0034633 | retinol transport | 1.307016e-8 |
GO:0048486 | parasympathetic nervous system development | 3.232269e-8 |
GO:0002339 | B cell selection | 8.475758e-8 |
GO:0002432 | granuloma formation | 1.666475e-7 |
GO:0071281 | cellular response to iron ion | 1.777758e-7 |
GO:0016574 | histone ubiquitination | 2.571929e-7 |
GO:0021623 | oculomotor nerve formation | 3.013980e-7 |
GO:0003409 | optic cup structural organization | 3.013980e-7 |
GO:0003404 | optic vesicle morphogenesis | 3.013980e-7 |
GO:0010610 | regulation of mRNA stability involved in response to stress | 4.854323e-7 |
GO:0070145 | mitochondrial asparaginyl-tRNA aminoacylation | 8.125722e-7 |
GO:0006352 | transcription initiation, DNA-dependent | 9.417475e-7 |
GO:0021612 | facial nerve structural organization | 9.770207e-7 |
GO:0021602 | cranial nerve morphogenesis | 1.057942e-6 |
GO:0045104 | intermediate filament cytoskeleton organization | 1.249755e-6 |
GO:0035518 | histone H2A monoubiquitination | 1.285911e-6 |
GO:0048561 | establishment of organ orientation | 1.383182e-6 |
GO:0070625 | zymogen granule exocytosis | 2.252699e-6 |
GO:0070816 | phosphorylation of RNA polymerase II C-terminal domain | 3.021271e-6 |
GO:0060379 | cardiac muscle cell myoblast differentiation | 3.413248e-6 |
GO:0072488 | ammonium transmembrane transport | 3.530974e-6 |
GO:0070170 | regulation of tooth mineralization | 3.584360e-6 |
GO:0033578 | protein glycosylation in Golgi | 3.857847e-6 |
GO:0021557 | oculomotor nerve development | 4.006548e-6 |
GO:0042998 | positive regulation of Golgi to plasma membrane protein transport | 4.762349e-6 |
GO:0045103 | intermediate filament-based process | 4.850658e-6 |
GO:0006983 | ER overload response | 5.215312e-6 |
GO:0042363 | fat-soluble vitamin catabolic process | 5.778731e-6 |
GO:0021570 | rhombomere 4 development | 7.321727e-6 |
GO:0001844 | protein insertion into mitochondrial membrane involved in induction of apoptosis | 7.862569e-6 |
GO:0032416 | negative regulation of sodium:hydrogen antiporter activity | 1.082741e-5 |
GO:0006391 | transcription initiation from mitochondrial promoter | 1.082741e-5 |
GO:0033522 | histone H2A ubiquitination | 1.092147e-5 |
GO:0021569 | rhombomere 3 development | 1.095659e-5 |
GO:0021506 | anterior neuropore closure | 1.122062e-5 |
GO:0006354 | transcription elongation, DNA-dependent | 1.241835e-5 |
GO:0021604 | cranial nerve structural organization | 1.295824e-5 |
GO:0000414 | regulation of histone H3-K36 methylation | 1.301809e-5 |
GO:0050883 | musculoskeletal movement, spinal reflex action | 1.302255e-5 |
GO:2000077 | negative regulation of type B pancreatic cell development | 1.524583e-5 |
GO:0003257 | positive regulation of transcription from RNA polymerase II promoter involved in myocardial precursor cell differentiation | 1.622510e-5 |
GO:0019477 | L-lysine catabolic process | 1.622510e-5 |
GO:0021599 | abducens nerve formation | 1.622510e-5 |
GO:0007634 | optokinetic behavior | 1.622510e-5 |
GO:0035329 | hippo signaling cascade | 1.647448e-5 |
GO:0070634 | transepithelial ammonium transport | 1.787264e-5 |
GO:0008637 | apoptotic mitochondrial changes | 2.055656e-5 |
GO:0006384 | transcription initiation from RNA polymerase III promoter | 2.108626e-5 |
GO:2000286 | receptor internalization involved in canonical Wnt receptor signaling pathway | 2.155233e-5 |
GO:0051205 | protein insertion into membrane | 2.536305e-5 |
GO:0042593 | glucose homeostasis | 2.618567e-5 |
GO:0033326 | cerebrospinal fluid secretion | 2.628065e-5 |
GO:0048294 | negative regulation of isotype switching to IgE isotypes | 2.639986e-5 |
GO:0032581 | ER-dependent peroxisome organization | 2.812590e-5 |
GO:0050908 | detection of light stimulus involved in visual perception | 2.858097e-5 |
GO:0006333 | chromatin assembly or disassembly | 3.219416e-5 |
GO:0070172 | positive regulation of tooth mineralization | 3.448388e-5 |
GO:0032508 | DNA duplex unwinding | 3.665264e-5 |
GO:0006362 | transcription elongation from RNA polymerase I promoter | 3.955348e-5 |
GO:0043320 | natural killer cell degranulation | 4.621170e-5 |
GO:0010889 | regulation of sequestering of triglyceride | 4.833757e-5 |
GO:2000649 | regulation of sodium ion transmembrane transporter activity | 4.846514e-5 |
GO:0021610 | facial nerve morphogenesis | 5.545470e-5 |
GO:0060044 | negative regulation of cardiac muscle cell proliferation | 6.403383e-5 |
GO:0032392 | DNA geometric change | 6.636243e-5 |
GO:0035024 | negative regulation of Rho protein signal transduction | 7.408489e-5 |
GO:0006337 | nucleosome disassembly | 7.718664e-5 |
GO:0043461 | proton-transporting ATP synthase complex assembly | 8.067548e-5 |
GO:0051135 | positive regulation of NK T cell activation | 8.601443e-5 |
GO:0002467 | germinal center formation | 9.096662e-5 |
GO:0050432 | catecholamine secretion | 9.322473e-5 |
GO:0007614 | short-term memory | 9.347668e-5 |
GO:0048255 | mRNA stabilization | 9.378036e-5 |
GO:0070286 | axonemal dynein complex assembly | 1.023372e-4 |
GO:0070934 | CRD-mediated mRNA stabilization | 1.052311e-4 |
GO:0051204 | protein insertion into mitochondrial membrane | 1.052311e-4 |
GO:0021561 | facial nerve development | 1.052311e-4 |
GO:0045085 | negative regulation of interleukin-2 biosynthetic process | 1.079151e-4 |
GO:0045907 | positive regulation of vasoconstriction | 1.178820e-4 |
GO:0032425 | positive regulation of mismatch repair | 1.222084e-4 |
GO:0001757 | somite specification | 1.245480e-4 |
GO:0006398 | histone mRNA 3'-end processing | 1.422361e-4 |
GO:0030826 | regulation of cGMP biosynthetic process | 1.681161e-4 |
GO:0043380 | regulation of memory T cell differentiation | 1.690029e-4 |
GO:0051534 | negative regulation of NFAT protein import into nucleus | 1.719439e-4 |
GO:2000466 | negative regulation of glycogen (starch) synthase activity | 1.802593e-4 |
GO:0034723 | DNA replication-dependent nucleosome organization | 1.802593e-4 |
GO:0071526 | semaphorin-plexin signaling pathway | 1.994989e-4 |
GO:0033523 | histone H2B ubiquitination | 2.121680e-4 |
GO:0006363 | termination of RNA polymerase I transcription | 2.234643e-4 |
GO:0034770 | histone H4-K20 methylation | 2.310929e-4 |
GO:0032915 | positive regulation of transforming growth factor beta2 production | 2.440340e-4 |
GO:0002829 | negative regulation of type 2 immune response | 2.471716e-4 |
GO:0045786 | negative regulation of cell cycle | 2.639508e-4 |
GO:0072162 | metanephric mesenchymal cell differentiation | 2.778328e-4 |
GO:0043488 | regulation of mRNA stability | 2.781013e-4 |
GO:0034623 | cellular macromolecular complex disassembly | 2.789854e-4 |
GO:0021559 | trigeminal nerve development | 2.861756e-4 |
GO:0060041 | retina development in camera-type eye | 2.954265e-4 |
GO:0001662 | behavioral fear response | 3.103481e-4 |
GO:0060316 | positive regulation of ryanodine-sensitive calcium-release channel activity | 3.115246e-4 |
GO:0070127 | tRNA aminoacylation for mitochondrial protein translation | 3.238683e-4 |
GO:0061015 | snRNA import into nucleus | 3.257495e-4 |
GO:0006844 | acyl carnitine transport | 3.257495e-4 |
GO:0033622 | integrin activation | 3.257495e-4 |
GO:0003334 | keratinocyte development | 3.359432e-4 |
GO:0046134 | pyrimidine nucleoside biosynthetic process | 3.374839e-4 |
GO:0000959 | mitochondrial RNA metabolic process | 3.599287e-4 |
GO:0061383 | trabecula morphogenesis | 3.612739e-4 |
GO:0002642 | positive regulation of immunoglobulin biosynthetic process | 3.644827e-4 |
GO:0002072 | optic cup morphogenesis involved in camera-type eye development | 3.652935e-4 |
GO:0002209 | behavioral defense response | 3.977729e-4 |
GO:0021545 | cranial nerve development | 4.096207e-4 |
GO:0034976 | response to endoplasmic reticulum stress | 4.125899e-4 |
GO:0048857 | neural nucleus development | 4.127609e-4 |
GO:0006353 | transcription termination, DNA-dependent | 4.201932e-4 |
GO:2000378 | negative regulation of reactive oxygen species metabolic process | 4.221298e-4 |
GO:0030827 | negative regulation of cGMP biosynthetic process | 4.346590e-4 |
GO:0032069 | regulation of nuclease activity | 4.448278e-4 |
GO:0048619 | embryonic hindgut morphogenesis | 4.504885e-4 |
GO:0009304 | tRNA transcription | 4.514949e-4 |
GO:0060343 | trabecula formation | 4.524234e-4 |
GO:0009584 | detection of visible light | 4.757884e-4 |
GO:0007050 | cell cycle arrest | 4.897951e-4 |
GO:0046105 | thymidine biosynthetic process | 5.249675e-4 |
GO:0006361 | transcription initiation from RNA polymerase I promoter | 5.379604e-4 |
GO:0016056 | rhodopsin mediated signaling pathway | 5.904315e-4 |
GO:0032774 | RNA biosynthetic process | 6.074555e-4 |
GO:0006351 | transcription, DNA-dependent | 6.198139e-4 |
GO:0032984 | macromolecular complex disassembly | 6.552541e-4 |
GO:0034393 | positive regulation of smooth muscle cell apoptosis | 6.585092e-4 |
GO:0071333 | cellular response to glucose stimulus | 6.612633e-4 |
GO:0014916 | regulation of lung blood pressure | 7.087792e-4 |
GO:0002536 | respiratory burst involved in inflammatory response | 7.332421e-4 |
GO:0007005 | mitochondrion organization | 7.390336e-4 |
GO:0060770 | negative regulation of epithelial cell proliferation involved in prostate gland development | 7.854851e-4 |
GO:0006479 | protein methylation | 7.878767e-4 |
GO:0015696 | ammonium transport | 7.898706e-4 |
GO:0071109 | superior temporal gyrus development | 7.985801e-4 |
GO:0032468 | Golgi calcium ion homeostasis | 8.037163e-4 |
GO:0060876 | semicircular canal formation | 8.037163e-4 |
GO:0032472 | Golgi calcium ion transport | 8.037163e-4 |
GO:0030026 | cellular manganese ion homeostasis | 8.037163e-4 |
GO:0021914 | negative regulation of smoothened signaling pathway involved in ventral spinal cord patterning | 8.037163e-4 |
GO:0006281 | DNA repair | 8.095489e-4 |
GO:0048293 | regulation of isotype switching to IgE isotypes | 8.332623e-4 |
GO:0016570 | histone modification | 8.346146e-4 |
GO:0032075 | positive regulation of nuclease activity | 8.397798e-4 |
GO:0035767 | endothelial cell chemotaxis | 8.400049e-4 |
GO:0035865 | cellular response to potassium ion | 9.037480e-4 |
GO:0034651 | cortisol biosynthetic process | 9.037480e-4 |
GO:0032342 | aldosterone biosynthetic process | 9.037480e-4 |
GO:0032415 | regulation of sodium:hydrogen antiporter activity | 9.168198e-4 |
GO:0021546 | rhombomere development | 9.225741e-4 |
GO:0006366 | transcription from RNA polymerase II promoter | 9.661398e-4 |
GO:0043097 | pyrimidine nucleoside salvage | 9.702399e-4 |
GO:0048807 | female genitalia morphogenesis | 9.738121e-4 |
GO:0034645 | cellular macromolecule biosynthetic process | 9.809404e-4 |
GO:0035924 | cellular response to vascular endothelial growth factor stimulus | 9.873843e-4 |
GO:0042631 | cellular response to water deprivation | 9.975308e-4 |
GO:0006775 | fat-soluble vitamin metabolic process | 1.006710e-3 |
GO:0007158 | neuron cell-cell adhesion | 1.030300e-3 |
GO:0000416 | positive regulation of histone H3-K36 methylation | 1.040465e-3 |
GO:0051684 | maintenance of Golgi location | 1.047382e-3 |
GO:0030262 | apoptotic nuclear change | 1.066731e-3 |
GO:0051532 | regulation of NFAT protein import into nucleus | 1.073287e-3 |
GO:0009163 | nucleoside biosynthetic process | 1.085742e-3 |
GO:0015959 | diadenosine polyphosphate metabolic process | 1.100571e-3 |
GO:0071453 | cellular response to oxygen levels | 1.102126e-3 |
GO:0048560 | establishment of anatomical structure orientation | 1.206203e-3 |
GO:2000074 | regulation of type B pancreatic cell development | 1.236446e-3 |
GO:0061360 | optic chiasma development | 1.265276e-3 |
GO:0035799 | ureter maturation | 1.265276e-3 |
GO:2000597 | positive regulation of optic nerve formation | 1.265276e-3 |
GO:0006409 | tRNA export from nucleus | 1.265276e-3 |
GO:0021633 | optic nerve structural organization | 1.265276e-3 |
GO:0021650 | vestibulocochlear nerve formation | 1.265276e-3 |
GO:0071894 | histone H2B conserved C-terminal lysine ubiquitination | 1.282402e-3 |
GO:0032764 | negative regulation of mast cell cytokine production | 1.291330e-3 |
GO:0000290 | deadenylation-dependent decapping of nuclear-transcribed mRNA | 1.326449e-3 |
GO:0016569 | covalent chromatin modification | 1.335462e-3 |
GO:0032855 | positive regulation of Rac GTPase activity | 1.338656e-3 |
GO:0016142 | O-glycoside catabolic process | 1.365868e-3 |
GO:0048102 | autophagic cell death | 1.367971e-3 |
GO:0042596 | fear response | 1.466556e-3 |
GO:0006368 | transcription elongation from RNA polymerase II promoter | 1.467576e-3 |
GO:0006984 | ER-nucleus signaling pathway | 1.471001e-3 |
GO:0006613 | cotranslational protein targeting to membrane | 1.482416e-3 |
GO:0071322 | cellular response to carbohydrate stimulus | 1.534274e-3 |
GO:0033693 | neurofilament bundle assembly | 1.565104e-3 |
GO:0060157 | urinary bladder development | 1.568486e-3 |
GO:0072528 | pyrimidine-containing compound biosynthetic process | 1.609055e-3 |
GO:0001678 | cellular glucose homeostasis | 1.654770e-3 |
GO:0009059 | macromolecule biosynthetic process | 1.677260e-3 |
GO:0006370 | mRNA capping | 1.742862e-3 |
GO:0042572 | retinol metabolic process | 1.772712e-3 |
GO:0006309 | DNA fragmentation involved in apoptotic nuclear change | 1.781503e-3 |
GO:0000002 | mitochondrial genome maintenance | 1.822299e-3 |
GO:0043487 | regulation of RNA stability | 1.872282e-3 |
GO:0006083 | acetate metabolic process | 1.905881e-3 |
GO:0034551 | mitochondrial respiratory chain complex III assembly | 1.970594e-3 |
GO:0060900 | embryonic camera-type eye formation | 2.017979e-3 |
GO:0006383 | transcription from RNA polymerase III promoter | 2.021085e-3 |
GO:0051256 | spindle midzone assembly involved in mitosis | 2.061821e-3 |
GO:0070071 | proton-transporting two-sector ATPase complex assembly | 2.139058e-3 |
GO:0034728 | nucleosome organization | 2.142145e-3 |
GO:0006259 | DNA metabolic process | 2.178622e-3 |
GO:0061178 | regulation of insulin secretion involved in cellular response to glucose stimulus | 2.186655e-3 |
GO:0032070 | regulation of deoxyribonuclease activity | 2.214098e-3 |
GO:0044258 | intestinal lipid catabolic process | 2.261246e-3 |
GO:0018350 | protein esterification | 2.261246e-3 |
GO:0070317 | negative regulation of G0 to G1 transition | 2.334112e-3 |
GO:0035815 | positive regulation of renal sodium excretion | 2.392760e-3 |
GO:0072303 | positive regulation of glomerular metanephric mesangial cell proliferation | 2.409260e-3 |
GO:0061384 | heart trabecular morphogenesis | 2.433364e-3 |
GO:0030501 | positive regulation of bone mineralization | 2.489801e-3 |
GO:0051668 | localization within membrane | 2.516454e-3 |
GO:0030237 | female sex determination | 2.579496e-3 |
GO:0045110 | intermediate filament bundle assembly | 2.615654e-3 |
GO:0044245 | polysaccharide digestion | 2.615654e-3 |
GO:0042520 | positive regulation of tyrosine phosphorylation of Stat4 protein | 2.638204e-3 |
GO:0072298 | regulation of metanephric glomerulus development | 2.677306e-3 |
GO:0035774 | positive regulation of insulin secretion involved in cellular response to glucose stimulus | 2.765577e-3 |
GO:0002125 | maternal aggressive behavior | 2.791282e-3 |
GO:0072300 | positive regulation of metanephric glomerulus development | 2.800042e-3 |
GO:0021675 | nerve development | 2.811573e-3 |
GO:0042524 | negative regulation of tyrosine phosphorylation of Stat5 protein | 2.843777e-3 |
GO:0044249 | cellular biosynthetic process | 2.857815e-3 |
GO:0006270 | DNA-dependent DNA replication initiation | 2.897687e-3 |
GO:0000415 | negative regulation of histone H3-K36 methylation | 2.931686e-3 |
GO:0043471 | regulation of cellular carbohydrate catabolic process | 2.935105e-3 |
GO:0016575 | histone deacetylation | 3.015721e-3 |
GO:2000036 | regulation of stem cell maintenance | 3.055282e-3 |
GO:0060347 | heart trabecula formation | 3.122590e-3 |
GO:0010661 | positive regulation of muscle cell apoptosis | 3.122590e-3 |
GO:0045608 | negative regulation of auditory receptor cell differentiation | 3.145100e-3 |
GO:0030828 | positive regulation of cGMP biosynthetic process | 3.226384e-3 |
GO:0097029 | mature dendritic cell differentiation | 3.290731e-3 |
GO:0000022 | mitotic spindle elongation | 3.290731e-3 |
GO:0060600 | dichotomous subdivision of an epithelial terminal unit | 3.312734e-3 |
GO:0010944 | negative regulation of transcription by competitive promoter binding | 3.346513e-3 |
GO:0001912 | positive regulation of leukocyte mediated cytotoxicity | 3.352135e-3 |
GO:0090251 | protein localization involved in establishment of planar polarity | 3.469841e-3 |
GO:0034776 | response to histamine | 3.469841e-3 |
GO:0021758 | putamen development | 3.469841e-3 |
GO:0021757 | caudate nucleus development | 3.469841e-3 |
GO:0009452 | RNA capping | 3.476308e-3 |
GO:0007099 | centriole replication | 3.541886e-3 |
GO:0060042 | retina morphogenesis in camera-type eye | 3.543896e-3 |
GO:0002637 | regulation of immunoglobulin production | 3.615313e-3 |
GO:0010573 | vascular endothelial growth factor production | 3.679924e-3 |
GO:0090051 | negative regulation of cell migration involved in sprouting angiogenesis | 3.687342e-3 |
GO:0060904 | regulation of protein folding in endoplasmic reticulum | 3.687342e-3 |
GO:0021589 | cerebellum structural organization | 3.687342e-3 |
GO:0016082 | synaptic vesicle priming | 3.747463e-3 |
GO:0007029 | endoplasmic reticulum organization | 3.801668e-3 |
GO:0019896 | axon transport of mitochondrion | 3.820886e-3 |
GO:0009416 | response to light stimulus | 3.843823e-3 |
GO:0090304 | nucleic acid metabolic process | 3.883453e-3 |
GO:0048702 | embryonic neurocranium morphogenesis | 3.937919e-3 |
GO:0006614 | SRP-dependent cotranslational protein targeting to membrane | 4.097145e-3 |
GO:0070874 | negative regulation of glycogen metabolic process | 4.138350e-3 |
GO:0051541 | elastin metabolic process | 4.231923e-3 |
GO:0042360 | vitamin E metabolic process | 4.259138e-3 |
GO:0034446 | substrate adhesion-dependent cell spreading | 4.328880e-3 |
GO:0006120 | mitochondrial electron transport, NADH to ubiquinone | 4.365534e-3 |
GO:0033615 | mitochondrial proton-transporting ATP synthase complex assembly | 4.558796e-3 |
GO:0048010 | vascular endothelial growth factor receptor signaling pathway | 4.560773e-3 |
GO:0001843 | neural tube closure | 4.776853e-3 |
GO:0032071 | regulation of endodeoxyribonuclease activity | 4.837296e-3 |
GO:0044240 | multicellular organismal lipid catabolic process | 4.850098e-3 |
GO:0060314 | regulation of ryanodine-sensitive calcium-release channel activity | 5.043107e-3 |
GO:0070169 | positive regulation of biomineral tissue development | 5.089858e-3 |
GO:0060349 | bone morphogenesis | 5.126298e-3 |
GO:0060629 | regulation of homologous chromosome segregation | 5.255225e-3 |
GO:0010760 | negative regulation of macrophage chemotaxis | 5.255225e-3 |
GO:0051598 | meiotic recombination checkpoint | 5.255225e-3 |
GO:0034968 | histone lysine methylation | 5.260561e-3 |
GO:0060666 | dichotomous subdivision of terminal units involved in salivary gland branching | 5.312390e-3 |
GO:0008090 | retrograde axon cargo transport | 5.312390e-3 |
GO:0017004 | cytochrome complex assembly | 5.312723e-3 |
GO:0003406 | retinal pigment epithelium development | 5.312723e-3 |
GO:0006421 | asparaginyl-tRNA aminoacylation | 5.526212e-3 |
GO:0016226 | iron-sulfur cluster assembly | 5.542331e-3 |
GO:0021884 | forebrain neuron development | 5.542331e-3 |
GO:0038007 | netrin-activated signaling pathway | 5.634886e-3 |
GO:0071456 | cellular response to hypoxia | 5.663432e-3 |
GO:0030500 | regulation of bone mineralization | 5.738390e-3 |
GO:0060606 | tube closure | 5.809028e-3 |
GO:0010812 | negative regulation of cell-substrate adhesion | 5.854799e-3 |
GO:0001916 | positive regulation of T cell mediated cytotoxicity | 5.987514e-3 |
GO:2000109 | regulation of macrophage apoptosis | 6.056896e-3 |
GO:0051902 | negative regulation of mitochondrial depolarization | 6.145509e-3 |
GO:0021754 | facial nucleus development | 6.153953e-3 |
GO:0035566 | regulation of metanephros size | 6.153953e-3 |
GO:2000225 | negative regulation of testosterone biosynthetic process | 6.205314e-3 |
GO:2000066 | positive regulation of cortisol biosynthetic process | 6.205314e-3 |
GO:0033080 | immature T cell proliferation in thymus | 6.205314e-3 |
GO:2000019 | negative regulation of male gonad development | 6.205314e-3 |
GO:0061369 | negative regulation of testicular blood vessel morphogenesis | 6.205314e-3 |
GO:0046511 | sphinganine biosynthetic process | 6.206947e-3 |
GO:0009450 | gamma-aminobutyric acid catabolic process | 6.251139e-3 |
GO:0043619 | regulation of transcription from RNA polymerase II promoter in response to oxidative stress | 6.408323e-3 |
GO:0021571 | rhombomere 5 development | 6.463051e-3 |
GO:0048247 | lymphocyte chemotaxis | 6.467372e-3 |
GO:0070328 | triglyceride homeostasis | 6.490089e-3 |
GO:0070171 | negative regulation of tooth mineralization | 6.553866e-3 |
GO:0032963 | collagen metabolic process | 6.563749e-3 |
GO:0032510 | endosome to lysosome transport via multivesicular body sorting pathway | 6.691393e-3 |
GO:0030823 | regulation of cGMP metabolic process | 6.710859e-3 |
GO:0060052 | neurofilament cytoskeleton organization | 6.713778e-3 |
GO:0001523 | retinoid metabolic process | 6.862058e-3 |
GO:0014020 | primary neural tube formation | 6.908462e-3 |
GO:0045819 | positive regulation of glycogen catabolic process | 7.044548e-3 |
GO:0006360 | transcription from RNA polymerase I promoter | 7.068730e-3 |
GO:0034505 | tooth mineralization | 7.071386e-3 |
GO:0006308 | DNA catabolic process | 7.104049e-3 |
GO:0042355 | L-fucose catabolic process | 7.147509e-3 |
GO:0006213 | pyrimidine nucleoside metabolic process | 7.219702e-3 |
GO:0044236 | multicellular organismal metabolic process | 7.309683e-3 |
GO:0006110 | regulation of glycolysis | 7.313191e-3 |
GO:0006617 | SRP-dependent cotranslational protein targeting to membrane, signal sequence recognition | 7.383535e-3 |
GO:0006616 | SRP-dependent cotranslational protein targeting to membrane, translocation | 7.383535e-3 |
GO:0090192 | regulation of glomerulus development | 7.444153e-3 |
GO:0071824 | protein-DNA complex subunit organization | 7.475321e-3 |
GO:0008089 | anterograde axon cargo transport | 7.508700e-3 |
GO:0032701 | negative regulation of interleukin-18 production | 7.600913e-3 |
GO:2000110 | negative regulation of macrophage apoptosis | 7.600913e-3 |
GO:2000363 | positive regulation of prostaglandin-E synthase activity | 7.600913e-3 |
GO:0071608 | macrophage inflammatory protein-1 alpha production | 7.600913e-3 |
GO:0006965 | positive regulation of biosynthetic process of antibacterial peptides active against Gram-positive bacteria | 7.600913e-3 |
GO:0009399 | nitrogen fixation | 7.600913e-3 |
GO:0032498 | detection of muramyl dipeptide | 7.600913e-3 |
GO:0061298 | retina vasculature development in camera-type eye | 7.623435e-3 |
GO:0034470 | ncRNA processing | 7.734066e-3 |
GO:0032423 | regulation of mismatch repair | 7.763952e-3 |
GO:0045607 | regulation of auditory receptor cell differentiation | 7.781221e-3 |
GO:0006499 | N-terminal protein myristoylation | 7.807709e-3 |
GO:0000917 | barrier septum formation | 7.807709e-3 |
GO:0006288 | base-excision repair, DNA ligation | 7.910145e-3 |
GO:0031167 | rRNA methylation | 7.910145e-3 |
GO:0035854 | eosinophil fate commitment | 7.910145e-3 |
GO:0030222 | eosinophil differentiation | 7.910145e-3 |
GO:0048172 | regulation of short-term neuronal synaptic plasticity | 7.929415e-3 |
GO:0090193 | positive regulation of glomerulus development | 8.037935e-3 |
GO:0070943 | neutrophil mediated killing of symbiont cell | 8.120302e-3 |
GO:0001996 | positive regulation of heart rate by epinephrine-norepinephrine | 8.133706e-3 |
GO:0048384 | retinoic acid receptor signaling pathway | 8.277247e-3 |
GO:0033539 | fatty acid beta-oxidation using acyl-CoA dehydrogenase | 8.484761e-3 |
GO:0006386 | termination of RNA polymerase III transcription | 8.591837e-3 |
GO:0006385 | transcription elongation from RNA polymerase III promoter | 8.591837e-3 |
GO:0006776 | vitamin A metabolic process | 8.604805e-3 |
GO:0061029 | eyelid development in camera-type eye | 8.798055e-3 |
GO:0000079 | regulation of cyclin-dependent protein kinase activity | 8.850577e-3 |
GO:2000275 | regulation of oxidative phosphorylation uncoupler activity | 8.868097e-3 |
GO:0043589 | skin morphogenesis | 8.938417e-3 |
GO:0051058 | negative regulation of small GTPase mediated signal transduction | 8.984068e-3 |
GO:0006356 | regulation of transcription from RNA polymerase I promoter | 9.015674e-3 |
GO:0016101 | diterpenoid metabolic process | 9.033879e-3 |
GO:0009074 | aromatic amino acid family catabolic process | 9.110294e-3 |
GO:0010155 | regulation of proton transport | 9.138362e-3 |
GO:0060080 | regulation of inhibitory postsynaptic membrane potential | 9.138362e-3 |
GO:0055119 | relaxation of cardiac muscle | 9.220190e-3 |
GO:0006390 | transcription from mitochondrial promoter | 9.255196e-3 |
GO:0006367 | transcription initiation from RNA polymerase II promoter | 9.272424e-3 |
GO:0006325 | chromatin organization | 9.312145e-3 |
GO:0001938 | positive regulation of endothelial cell proliferation | 9.445733e-3 |
GO:2001022 | positive regulation of response to DNA damage stimulus | 9.546581e-3 |
GO:0043174 | nucleoside salvage | 9.591218e-3 |
GO:0016140 | O-glycoside metabolic process | 9.659498e-3 |
GO:0032509 | endosome transport via multivesicular body sorting pathway | 9.686965e-3 |
GO:0035434 | copper ion transmembrane transport | 9.760588e-3 |
GO:0001709 | cell fate determination | 1.032837e-2 |
GO:0070345 | negative regulation of fat cell proliferation | 1.050118e-2 |
GO:0042092 | type 2 immune response | 1.060795e-2 |
GO:0006476 | protein deacetylation | 1.065467e-2 |
GO:0048554 | positive regulation of metalloenzyme activity | 1.095314e-2 |
GO:0071464 | cellular response to hydrostatic pressure | 1.097692e-2 |
GO:0016558 | protein import into peroxisome matrix | 1.110058e-2 |
GO:0030538 | embryonic genitalia morphogenesis | 1.122041e-2 |
GO:0090090 | negative regulation of canonical Wnt receptor signaling pathway | 1.135943e-2 |
GO:0051898 | negative regulation of protein kinase B signaling cascade | 1.143731e-2 |
GO:0032909 | regulation of transforming growth factor beta2 production | 1.151882e-2 |
GO:0070167 | regulation of biomineral tissue development | 1.154949e-2 |
GO:0046716 | muscle cell homeostasis | 1.158200e-2 |
GO:0042789 | mRNA transcription from RNA polymerase II promoter | 1.167805e-2 |
GO:0051572 | negative regulation of histone H3-K4 methylation | 1.174326e-2 |
GO:0010189 | vitamin E biosynthetic process | 1.177432e-2 |
GO:0048242 | epinephrine secretion | 1.182696e-2 |
GO:0051103 | DNA ligation involved in DNA repair | 1.188475e-2 |
GO:0006678 | glucosylceramide metabolic process | 1.188475e-2 |
GO:0045654 | positive regulation of megakaryocyte differentiation | 1.193290e-2 |
GO:0006654 | phosphatidic acid biosynthetic process | 1.193290e-2 |
GO:0043084 | penile erection | 1.193290e-2 |
GO:0046580 | negative regulation of Ras protein signal transduction | 1.213404e-2 |
GO:0065002 | intracellular protein transmembrane transport | 1.216797e-2 |
GO:0043414 | macromolecule methylation | 1.246505e-2 |
GO:0072111 | cell proliferation involved in kidney development | 1.269773e-2 |
GO:0060591 | chondroblast differentiation | 1.272891e-2 |
GO:0045906 | negative regulation of vasoconstriction | 1.272891e-2 |
GO:0007501 | mesodermal cell fate specification | 1.272891e-2 |
GO:0033483 | gas homeostasis | 1.283281e-2 |
GO:0072301 | regulation of metanephric glomerular mesangial cell proliferation | 1.283875e-2 |
GO:0033484 | nitric oxide homeostasis | 1.283875e-2 |
GO:0001958 | endochondral ossification | 1.284805e-2 |
GO:0035601 | protein deacylation | 1.292033e-2 |
GO:0045821 | positive regulation of glycolysis | 1.300447e-2 |
GO:0045749 | negative regulation of S phase of mitotic cell cycle | 1.300447e-2 |
GO:0010822 | positive regulation of mitochondrion organization | 1.300447e-2 |
GO:0010634 | positive regulation of epithelial cell migration | 1.304805e-2 |
GO:0046601 | positive regulation of centriole replication | 1.311902e-2 |
GO:0018146 | keratan sulfate biosynthetic process | 1.311902e-2 |
GO:0010266 | response to vitamin B1 | 1.311902e-2 |
GO:0021562 | vestibulocochlear nerve development | 1.333836e-2 |
GO:0045652 | regulation of megakaryocyte differentiation | 1.342214e-2 |
GO:0090399 | replicative senescence | 1.353898e-2 |
GO:0090049 | regulation of cell migration involved in sprouting angiogenesis | 1.354023e-2 |
GO:0006498 | N-terminal protein lipidation | 1.363924e-2 |
GO:0021997 | neural plate axis specification | 1.363924e-2 |
GO:0001555 | oocyte growth | 1.388560e-2 |
GO:0051569 | regulation of histone H3-K4 methylation | 1.389318e-2 |
GO:0010800 | positive regulation of peptidyl-threonine phosphorylation | 1.389709e-2 |
GO:0060027 | convergent extension involved in gastrulation | 1.392344e-2 |
GO:0051594 | detection of glucose | 1.392344e-2 |
GO:0060126 | somatotropin secreting cell differentiation | 1.400716e-2 |
GO:0046322 | negative regulation of fatty acid oxidation | 1.400716e-2 |
GO:0044259 | multicellular organismal macromolecule metabolic process | 1.442295e-2 |
GO:0060215 | primitive hemopoiesis | 1.444062e-2 |
GO:0007224 | smoothened signaling pathway | 1.466573e-2 |
GO:0035860 | glial cell-derived neurotrophic factor receptor signaling pathway | 1.482453e-2 |
GO:0000733 | DNA strand renaturation | 1.494053e-2 |
GO:0010842 | retina layer formation | 1.495591e-2 |
GO:0007140 | male meiosis | 1.504036e-2 |
GO:0006020 | inositol metabolic process | 1.506998e-2 |
GO:0006222 | UMP biosynthetic process | 1.511363e-2 |
GO:0010002 | cardioblast differentiation | 1.525109e-2 |
GO:0055118 | negative regulation of cardiac muscle contraction | 1.527630e-2 |
GO:0018345 | protein palmitoylation | 1.527630e-2 |
GO:0009411 | response to UV | 1.547738e-2 |
GO:0016556 | mRNA modification | 1.548015e-2 |
GO:0051145 | smooth muscle cell differentiation | 1.556443e-2 |
GO:0060490 | lateral sprouting involved in lung morphogenesis | 1.562934e-2 |
GO:0060489 | planar dichotomous subdivision of terminal units involved in lung branching morphogenesis | 1.562934e-2 |
GO:0046778 | modification by virus of host mRNA processing | 1.562934e-2 |
GO:0048105 | establishment of body hair planar orientation | 1.562934e-2 |
GO:0060488 | orthogonal dichotomous subdivision of terminal units involved in lung branching morphogenesis | 1.562934e-2 |
GO:0009058 | biosynthetic process | 1.569958e-2 |
GO:0060059 | embryonic retina morphogenesis in camera-type eye | 1.588567e-2 |
GO:0043588 | skin development | 1.603440e-2 |
GO:0034653 | retinoic acid catabolic process | 1.620951e-2 |
GO:0090200 | positive regulation of release of cytochrome c from mitochondria | 1.621762e-2 |
GO:0000154 | rRNA modification | 1.629690e-2 |
GO:0009583 | detection of light stimulus | 1.646783e-2 |
GO:0065001 | specification of axis polarity | 1.657306e-2 |
GO:0016070 | RNA metabolic process | 1.657757e-2 |
GO:0060346 | bone trabecula formation | 1.658040e-2 |
GO:0045629 | negative regulation of T-helper 2 cell differentiation | 1.658649e-2 |
GO:0035112 | genitalia morphogenesis | 1.662077e-2 |
GO:0035771 | interleukin-4-mediated signaling pathway | 1.667137e-2 |
GO:0006089 | lactate metabolic process | 1.672893e-2 |
GO:0021919 | BMP signaling pathway involved in spinal cord dorsal/ventral patterning | 1.684039e-2 |
GO:0006895 | Golgi to endosome transport | 1.686826e-2 |
GO:0006569 | tryptophan catabolic process | 1.689281e-2 |
GO:0045739 | positive regulation of DNA repair | 1.694694e-2 |
GO:0022904 | respiratory electron transport chain | 1.706096e-2 |
GO:0071603 | endothelial cell-cell adhesion | 1.745028e-2 |
GO:0060282 | positive regulation of oocyte development | 1.745028e-2 |
GO:0043508 | negative regulation of JUN kinase activity | 1.745868e-2 |
GO:0032526 | response to retinoic acid | 1.754883e-2 |
GO:0031557 | induction of programmed cell death in response to chemical stimulus | 1.760889e-2 |
GO:0034754 | cellular hormone metabolic process | 1.771392e-2 |
GO:0007195 | inhibition of adenylate cyclase activity by dopamine receptor signaling pathway | 1.772447e-2 |
GO:0045175 | basal protein localization | 1.780391e-2 |
GO:0030264 | nuclear fragmentation involved in apoptotic nuclear change | 1.785727e-2 |
GO:0006235 | dTTP biosynthetic process | 1.785727e-2 |
GO:0060319 | primitive erythrocyte differentiation | 1.786975e-2 |
GO:0002575 | basophil chemotaxis | 1.786975e-2 |
GO:0072110 | glomerular mesangial cell proliferation | 1.797557e-2 |
GO:0051262 | protein tetramerization | 1.806857e-2 |
GO:0007006 | mitochondrial membrane organization | 1.818765e-2 |
GO:0006568 | tryptophan metabolic process | 1.822383e-2 |
GO:0045191 | regulation of isotype switching | 1.841504e-2 |
GO:0070863 | positive regulation of protein exit from endoplasmic reticulum | 1.853536e-2 |
GO:0022898 | regulation of transmembrane transporter activity | 1.861053e-2 |
GO:0006283 | transcription-coupled nucleotide-excision repair | 1.887363e-2 |
GO:0050890 | cognition | 1.894191e-2 |
GO:0002827 | positive regulation of T-helper 1 type immune response | 1.947378e-2 |
GO:0072126 | positive regulation of glomerular mesangial cell proliferation | 1.954627e-2 |
GO:0071506 | cellular response to mycophenolic acid | 1.954627e-2 |
GREAT analysis results for mouseGenomic Enrichment of Annotations Tool (GREAT, Nat Biotechnol. 2010 May;28(5):495-501) is used to identify, both in human and in mouse, the gene ontology terms of biological processes enriched given the predicted TFBSs, and evaluated the overlap in the top-500 gene ontology terms between human and mouse. For each novel motif, the P value for the overlap was then evaluated by calculating its relative rank with respect to this background distribution.<br>Analyst: Michiel de Hoon <br><br>link to source dataset <br>data
GO ID | GO Term | p-value |
---|---|---|
GO:0010467 | gene expression | 1.805350e-9 |
GO:0021604 | cranial nerve structural organization | 2.687465e-8 |
GO:0043154 | negative regulation of caspase activity | 3.209115e-8 |
GO:0006929 | substrate-dependent cell migration | 3.939712e-8 |
GO:0044260 | cellular macromolecule metabolic process | 4.513202e-8 |
GO:0090304 | nucleic acid metabolic process | 5.443296e-8 |
GO:0016070 | RNA metabolic process | 1.073588e-7 |
GO:0021612 | facial nerve structural organization | 1.133829e-7 |
GO:0034447 | very-low-density lipoprotein particle clearance | 1.426569e-7 |
GO:0034641 | cellular nitrogen compound metabolic process | 1.725147e-7 |
GO:0048532 | anatomical structure arrangement | 2.178026e-7 |
GO:0072161 | mesenchymal cell differentiation involved in kidney development | 2.352933e-7 |
GO:0006351 | transcription, DNA-dependent | 2.455533e-7 |
GO:0032774 | RNA biosynthetic process | 2.974880e-7 |
GO:0007168 | receptor guanylyl cyclase signaling pathway | 2.979451e-7 |
GO:0006139 | nucleobase-containing compound metabolic process | 3.341674e-7 |
GO:0021569 | rhombomere 3 development | 3.618384e-7 |
GO:0045017 | glycerolipid biosynthetic process | 4.151502e-7 |
GO:0044267 | cellular protein metabolic process | 4.320843e-7 |
GO:0009083 | branched chain family amino acid catabolic process | 5.153433e-7 |
GO:0006807 | nitrogen compound metabolic process | 5.272301e-7 |
GO:0034645 | cellular macromolecule biosynthetic process | 6.577311e-7 |
GO:0006457 | protein folding | 7.741849e-7 |
GO:0045345 | positive regulation of MHC class I biosynthetic process | 9.423689e-7 |
GO:0009059 | macromolecule biosynthetic process | 1.107284e-6 |
GO:0010900 | negative regulation of phosphatidylcholine catabolic process | 1.219507e-6 |
GO:0021610 | facial nerve morphogenesis | 1.253230e-6 |
GO:0032816 | positive regulation of natural killer cell activation | 1.447390e-6 |
GO:0034725 | DNA replication-dependent nucleosome disassembly | 1.638419e-6 |
GO:0035414 | negative regulation of catenin import into nucleus | 1.963370e-6 |
GO:0009081 | branched chain family amino acid metabolic process | 2.004072e-6 |
GO:0045343 | regulation of MHC class I biosynthetic process | 2.396454e-6 |
GO:0034968 | histone lysine methylation | 2.522928e-6 |
GO:0051135 | positive regulation of NK T cell activation | 3.033447e-6 |
GO:0021561 | facial nerve development | 3.734029e-6 |
GO:0071894 | histone H2B conserved C-terminal lysine ubiquitination | 5.207381e-6 |
GO:0002291 | T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell | 5.207381e-6 |
GO:0061205 | paramesonephric duct development | 5.270423e-6 |
GO:0021570 | rhombomere 4 development | 5.286504e-6 |
GO:0006402 | mRNA catabolic process | 5.516893e-6 |
GO:0046474 | glycerophospholipid biosynthetic process | 5.866959e-6 |
GO:0043170 | macromolecule metabolic process | 7.344388e-6 |
GO:0021602 | cranial nerve morphogenesis | 7.348377e-6 |
GO:0046327 | glycerol biosynthetic process from pyruvate | 8.463988e-6 |
GO:0045922 | negative regulation of fatty acid metabolic process | 9.077290e-6 |
GO:0016568 | chromatin modification | 9.428926e-6 |
GO:0042572 | retinol metabolic process | 9.648086e-6 |
GO:0018192 | enzyme active site formation via L-cysteine persulfide | 9.978962e-6 |
GO:0060669 | embryonic placenta morphogenesis | 1.127443e-5 |
GO:0032814 | regulation of natural killer cell activation | 1.145201e-5 |
GO:0072197 | ureter morphogenesis | 1.179991e-5 |
GO:0060670 | branching involved in embryonic placenta morphogenesis | 1.258384e-5 |
GO:0033523 | histone H2B ubiquitination | 1.305867e-5 |
GO:0006975 | DNA damage induced protein phosphorylation | 1.709298e-5 |
GO:0008616 | queuosine biosynthetic process | 1.775762e-5 |
GO:0034976 | response to endoplasmic reticulum stress | 1.828119e-5 |
GO:0006401 | RNA catabolic process | 1.934039e-5 |
GO:0046655 | folic acid metabolic process | 2.163741e-5 |
GO:0035329 | hippo signaling cascade | 2.227099e-5 |
GO:0006646 | phosphatidylethanolamine biosynthetic process | 2.438288e-5 |
GO:0045717 | negative regulation of fatty acid biosynthetic process | 2.470597e-5 |
GO:0060390 | regulation of SMAD protein import into nucleus | 2.674098e-5 |
GO:0006766 | vitamin metabolic process | 2.727687e-5 |
GO:0031365 | N-terminal protein amino acid modification | 2.758351e-5 |
GO:0018125 | peptidyl-cysteine methylation | 2.787698e-5 |
GO:0033239 | negative regulation of cellular amine metabolic process | 2.989853e-5 |
GO:0042921 | glucocorticoid receptor signaling pathway | 3.014166e-5 |
GO:0018022 | peptidyl-lysine methylation | 3.014166e-5 |
GO:0051084 | 'de novo' posttranslational protein folding | 3.339988e-5 |
GO:0060155 | platelet dense granule organization | 3.473927e-5 |
GO:0002344 | B cell affinity maturation | 3.473927e-5 |
GO:0021571 | rhombomere 5 development | 3.623570e-5 |
GO:0015884 | folic acid transport | 3.679829e-5 |
GO:0043501 | skeletal muscle adaptation | 3.811298e-5 |
GO:0060713 | labyrinthine layer morphogenesis | 4.393334e-5 |
GO:0048793 | pronephros development | 4.414002e-5 |
GO:0072077 | renal vesicle morphogenesis | 4.521615e-5 |
GO:0048662 | negative regulation of smooth muscle cell proliferation | 4.524412e-5 |
GO:0072162 | metanephric mesenchymal cell differentiation | 5.283551e-5 |
GO:0021546 | rhombomere development | 5.945143e-5 |
GO:0006289 | nucleotide-excision repair | 6.104561e-5 |
GO:0034767 | positive regulation of ion transmembrane transport | 6.364326e-5 |
GO:0006415 | translational termination | 6.454896e-5 |
GO:0060696 | regulation of phospholipid catabolic process | 6.853822e-5 |
GO:0006325 | chromatin organization | 7.322438e-5 |
GO:0018198 | peptidyl-cysteine modification | 7.917519e-5 |
GO:0031664 | regulation of lipopolysaccharide-mediated signaling pathway | 7.921757e-5 |
GO:0060691 | epithelial cell maturation involved in salivary gland development | 8.035410e-5 |
GO:0072428 | signal transduction involved in intra-S DNA damage checkpoint | 8.035410e-5 |
GO:0060096 | serotonin secretion, neurotransmission | 8.035410e-5 |
GO:0030823 | regulation of cGMP metabolic process | 8.595341e-5 |
GO:0031061 | negative regulation of histone methylation | 9.613964e-5 |
GO:0035621 | ER to Golgi ceramide transport | 1.024771e-4 |
GO:0060711 | labyrinthine layer development | 1.047100e-4 |
GO:0035799 | ureter maturation | 1.080057e-4 |
GO:0035269 | protein O-linked mannosylation | 1.080057e-4 |
GO:0061360 | optic chiasma development | 1.080057e-4 |
GO:2000597 | positive regulation of optic nerve formation | 1.080057e-4 |
GO:0021650 | vestibulocochlear nerve formation | 1.080057e-4 |
GO:0007144 | female meiosis I | 1.080057e-4 |
GO:0021633 | optic nerve structural organization | 1.080057e-4 |
GO:0035852 | horizontal cell localization | 1.182653e-4 |
GO:2000768 | positive regulation of nephron tubule epithelial cell differentiation | 1.182653e-4 |
GO:0035849 | nephric duct elongation | 1.182653e-4 |
GO:0042335 | cuticle development | 1.182653e-4 |
GO:0006348 | chromatin silencing at telomere | 1.182653e-4 |
GO:0035846 | oviduct epithelium development | 1.182653e-4 |
GO:0035847 | uterine epithelium development | 1.182653e-4 |
GO:0090190 | positive regulation of branching involved in ureteric bud morphogenesis | 1.298827e-4 |
GO:0007051 | spindle organization | 1.323687e-4 |
GO:0006281 | DNA repair | 1.482287e-4 |
GO:0016575 | histone deacetylation | 1.534027e-4 |
GO:0055025 | positive regulation of cardiac muscle tissue development | 1.543228e-4 |
GO:0032825 | positive regulation of natural killer cell differentiation | 1.577313e-4 |
GO:0072283 | metanephric renal vesicle morphogenesis | 1.644524e-4 |
GO:0006104 | succinyl-CoA metabolic process | 1.685471e-4 |
GO:0016570 | histone modification | 1.787810e-4 |
GO:0072087 | renal vesicle development | 1.799193e-4 |
GO:0048096 | chromatin-mediated maintenance of transcription | 1.914607e-4 |
GO:0014707 | branchiomeric skeletal muscle development | 1.931471e-4 |
GO:0002098 | tRNA wobble uridine modification | 1.931471e-4 |
GO:0014732 | skeletal muscle atrophy | 1.971092e-4 |
GO:0008617 | guanosine metabolic process | 2.175002e-4 |
GO:0016569 | covalent chromatin modification | 2.252167e-4 |
GO:0006659 | phosphatidylserine biosynthetic process | 2.282851e-4 |
GO:0007214 | gamma-aminobutyric acid signaling pathway | 2.315765e-4 |
GO:0030520 | estrogen receptor signaling pathway | 2.390198e-4 |
GO:0051225 | spindle assembly | 2.396726e-4 |
GO:0044249 | cellular biosynthetic process | 2.423824e-4 |
GO:0014889 | muscle atrophy | 2.494215e-4 |
GO:0021562 | vestibulocochlear nerve development | 2.546206e-4 |
GO:0019348 | dolichol metabolic process | 2.546206e-4 |
GO:0021985 | neurohypophysis development | 2.627906e-4 |
GO:0010466 | negative regulation of peptidase activity | 2.725193e-4 |
GO:0018026 | peptidyl-lysine monomethylation | 2.859129e-4 |
GO:0009082 | branched chain family amino acid biosynthetic process | 2.917145e-4 |
GO:0007049 | cell cycle | 3.040340e-4 |
GO:0000956 | nuclear-transcribed mRNA catabolic process | 3.134601e-4 |
GO:0044154 | histone H3-K14 acetylation | 3.251485e-4 |
GO:0002011 | morphogenesis of an epithelial sheet | 3.279233e-4 |
GO:0031958 | corticosteroid receptor signaling pathway | 3.507866e-4 |
GO:0032092 | positive regulation of protein binding | 3.809904e-4 |
GO:0043928 | exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay | 3.922421e-4 |
GO:0090090 | negative regulation of canonical Wnt receptor signaling pathway | 4.020179e-4 |
GO:0003382 | epithelial cell morphogenesis | 4.065646e-4 |
GO:0034227 | tRNA thio-modification | 4.105088e-4 |
GO:0002831 | regulation of response to biotic stimulus | 4.144779e-4 |
GO:0051346 | negative regulation of hydrolase activity | 4.191277e-4 |
GO:0003337 | mesenchymal to epithelial transition involved in metanephros morphogenesis | 4.294819e-4 |
GO:0002381 | immunoglobulin production involved in immunoglobulin mediated immune response | 4.306628e-4 |
GO:0030825 | positive regulation of cGMP metabolic process | 4.500060e-4 |
GO:0090189 | regulation of branching involved in ureteric bud morphogenesis | 4.553809e-4 |
GO:0035502 | metanephric ureteric bud development | 4.556516e-4 |
GO:0090184 | positive regulation of kidney development | 4.746100e-4 |
GO:0021603 | cranial nerve formation | 4.834790e-4 |
GO:0060067 | cervix development | 5.258595e-4 |
GO:0014916 | regulation of lung blood pressure | 5.258595e-4 |
GO:0010390 | histone monoubiquitination | 5.363572e-4 |
GO:0021979 | hypothalamus cell differentiation | 5.645835e-4 |
GO:0010722 | regulation of ferrochelatase activity | 5.645835e-4 |
GO:0072104 | glomerular capillary formation | 5.855477e-4 |
GO:0061381 | cell migration in diencephalon | 5.989541e-4 |
GO:0010045 | response to nickel ion | 5.989541e-4 |
GO:0061379 | inferior colliculus development | 5.989541e-4 |
GO:0021855 | hypothalamus cell migration | 5.989541e-4 |
GO:0061374 | mammillothalamic axonal tract development | 5.989541e-4 |
GO:0043281 | regulation of cysteine-type endopeptidase activity involved in apoptotic process | 6.107707e-4 |
GO:0072176 | nephric duct development | 6.108728e-4 |
GO:0008654 | phospholipid biosynthetic process | 6.336213e-4 |
GO:0034770 | histone H4-K20 methylation | 6.612130e-4 |
GO:0006551 | leucine metabolic process | 6.831616e-4 |
GO:0003406 | retinal pigment epithelium development | 6.831616e-4 |
GO:0000414 | regulation of histone H3-K36 methylation | 6.831616e-4 |
GO:0000184 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay | 7.247221e-4 |
GO:0002827 | positive regulation of T-helper 1 type immune response | 7.476482e-4 |
GO:0035412 | regulation of catenin import into nucleus | 7.701794e-4 |
GO:0001886 | endothelial cell morphogenesis | 8.129776e-4 |
GO:0006464 | protein modification process | 8.248757e-4 |
GO:0032660 | regulation of interleukin-17 production | 8.545015e-4 |
GO:0090199 | regulation of release of cytochrome c from mitochondria | 8.577037e-4 |
GO:0045918 | negative regulation of cytolysis | 8.732207e-4 |
GO:0018283 | iron incorporation into metallo-sulfur cluster | 8.732207e-4 |
GO:0006114 | glycerol biosynthetic process | 8.850420e-4 |
GO:2000623 | negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay | 9.458907e-4 |
GO:0060686 | negative regulation of prostatic bud formation | 9.469965e-4 |
GO:0070368 | positive regulation of hepatocyte differentiation | 9.594144e-4 |
GO:0006499 | N-terminal protein myristoylation | 9.594144e-4 |
GO:0031665 | negative regulation of lipopolysaccharide-mediated signaling pathway | 9.756090e-4 |
GO:0043500 | muscle adaptation | 9.902329e-4 |
GO:0072015 | glomerular visceral epithelial cell development | 1.024647e-3 |
GO:0006986 | response to unfolded protein | 1.038015e-3 |
GO:2000116 | regulation of cysteine-type endopeptidase activity | 1.038731e-3 |
GO:0072205 | metanephric collecting duct development | 1.059281e-3 |
GO:0016226 | iron-sulfur cluster assembly | 1.059281e-3 |
GO:0072192 | ureter epithelial cell differentiation | 1.071424e-3 |
GO:0072198 | mesenchymal cell proliferation involved in ureter development | 1.071424e-3 |
GO:0072138 | mesenchymal cell proliferation involved in ureteric bud development | 1.071424e-3 |
GO:0072101 | specification of ureteric bud anterior/posterior symmetry by BMP signaling pathway | 1.071424e-3 |
GO:0072097 | negative regulation of branch elongation involved in ureteric bud branching by BMP signaling pathway | 1.071424e-3 |
GO:2000005 | negative regulation of metanephric S-shaped body morphogenesis | 1.071424e-3 |
GO:2000137 | negative regulation of cell proliferation involved in heart morphogenesis | 1.071424e-3 |
GO:2000007 | negative regulation of metanephric comma-shaped body morphogenesis | 1.071424e-3 |
GO:0090194 | negative regulation of glomerulus development | 1.071424e-3 |
GO:0090191 | negative regulation of branching involved in ureteric bud morphogenesis | 1.071424e-3 |
GO:0072200 | negative regulation of mesenchymal cell proliferation involved in ureter development | 1.071424e-3 |
GO:0060502 | epithelial cell proliferation involved in lung morphogenesis | 1.071424e-3 |
GO:0018343 | protein farnesylation | 1.071424e-3 |
GO:0007500 | mesodermal cell fate determination | 1.071424e-3 |
GO:0000415 | negative regulation of histone H3-K36 methylation | 1.071424e-3 |
GO:0071893 | BMP signaling pathway involved in nephric duct formation | 1.071424e-3 |
GO:0048392 | intermediate mesodermal cell differentiation | 1.071424e-3 |
GO:0050747 | positive regulation of lipoprotein metabolic process | 1.071424e-3 |
GO:0061155 | pulmonary artery endothelial tube morphogenesis | 1.071424e-3 |
GO:0061151 | BMP signaling pathway involved in renal system segmentation | 1.071424e-3 |
GO:0061149 | BMP signaling pathway involved in ureter morphogenesis | 1.071424e-3 |
GO:0055020 | positive regulation of cardiac muscle fiber development | 1.071424e-3 |
GO:0060503 | bud dilation involved in lung branching | 1.071424e-3 |
GO:0002339 | B cell selection | 1.073565e-3 |
GO:0061110 | dense core granule biogenesis | 1.097314e-3 |
GO:0090331 | negative regulation of platelet aggregation | 1.097314e-3 |
GO:0014878 | response to electrical stimulus involved in regulation of muscle adaptation | 1.097314e-3 |
GO:0061108 | seminal vesicle epithelium development | 1.097314e-3 |
GO:0003085 | negative regulation of systemic arterial blood pressure | 1.174409e-3 |
GO:0072573 | tolerance induction to lipopolysaccharide | 1.176607e-3 |
GO:0070433 | negative regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway | 1.176607e-3 |
GO:2000349 | negative regulation of CD40 signaling pathway | 1.176607e-3 |
GO:0070429 | negative regulation of nucleotide-binding oligomerization domain containing 1 signaling pathway | 1.176607e-3 |
GO:0002632 | negative regulation of granuloma formation | 1.176607e-3 |
GO:0034148 | negative regulation of toll-like receptor 5 signaling pathway | 1.176607e-3 |
GO:0006775 | fat-soluble vitamin metabolic process | 1.209422e-3 |
GO:0051276 | chromosome organization | 1.211690e-3 |
GO:0043983 | histone H4-K12 acetylation | 1.213623e-3 |
GO:0045906 | negative regulation of vasoconstriction | 1.218095e-3 |
GO:0010388 | cullin deneddylation | 1.218095e-3 |
GO:0010916 | negative regulation of very-low-density lipoprotein particle clearance | 1.233831e-3 |
GO:0019538 | protein metabolic process | 1.360830e-3 |
GO:2000594 | positive regulation of metanephric DCT cell differentiation | 1.372894e-3 |
GO:0072305 | negative regulation of mesenchymal stem cell apoptosis involved in metanephric nephron morphogenesis | 1.372894e-3 |
GO:0019230 | proprioception | 1.372894e-3 |
GO:0039003 | pronephric field specification | 1.372894e-3 |
GO:0042520 | positive regulation of tyrosine phosphorylation of Stat4 protein | 1.418393e-3 |
GO:0006933 | negative regulation of cell adhesion involved in substrate-bound cell migration | 1.423791e-3 |
GO:0000114 | regulation of transcription involved in G1 phase of mitotic cell cycle | 1.423791e-3 |
GO:0009058 | biosynthetic process | 1.436633e-3 |
GO:0021919 | BMP signaling pathway involved in spinal cord dorsal/ventral patterning | 1.449093e-3 |
GO:0034144 | negative regulation of toll-like receptor 4 signaling pathway | 1.470878e-3 |
GO:0030501 | positive regulation of bone mineralization | 1.500638e-3 |
GO:0006412 | translation | 1.521758e-3 |
GO:0090192 | regulation of glomerulus development | 1.592273e-3 |
GO:0031117 | positive regulation of microtubule depolymerization | 1.625035e-3 |
GO:0006855 | drug transmembrane transport | 1.625428e-3 |
GO:0060674 | placenta blood vessel development | 1.630207e-3 |
GO:0046622 | positive regulation of organ growth | 1.630207e-3 |
GO:0072003 | kidney rudiment formation | 1.692401e-3 |
GO:0019432 | triglyceride biosynthetic process | 1.694636e-3 |
GO:0006366 | transcription from RNA polymerase II promoter | 1.697445e-3 |
GO:2000347 | positive regulation of hepatocyte proliferation | 1.744469e-3 |
GO:0070169 | positive regulation of biomineral tissue development | 1.795124e-3 |
GO:0072177 | mesonephric duct development | 1.811833e-3 |
GO:0048631 | regulation of skeletal muscle tissue growth | 1.854610e-3 |
GO:0046963 | 3'-phosphoadenosine 5'-phosphosulfate transport | 1.854610e-3 |
GO:0010971 | positive regulation of G2/M transition of mitotic cell cycle | 1.854610e-3 |
GO:0035990 | tendon cell differentiation | 1.854610e-3 |
GO:0006776 | vitamin A metabolic process | 1.896732e-3 |
GO:0001658 | branching involved in ureteric bud morphogenesis | 1.913490e-3 |
GO:0045332 | phospholipid translocation | 1.920176e-3 |
GO:0035993 | deltoid tuberosity development | 1.920176e-3 |
GO:0006505 | GPI anchor metabolic process | 1.930707e-3 |
GO:0032786 | positive regulation of transcription elongation, DNA-dependent | 1.976158e-3 |
GO:0072178 | nephric duct morphogenesis | 1.994425e-3 |
GO:0014888 | striated muscle adaptation | 2.014885e-3 |
GO:0018208 | peptidyl-proline modification | 2.046882e-3 |
GO:0035566 | regulation of metanephros size | 2.065287e-3 |
GO:0033578 | protein glycosylation in Golgi | 2.065287e-3 |
GO:0048633 | positive regulation of skeletal muscle tissue growth | 2.089366e-3 |
GO:0035573 | N-terminal peptidyl-serine trimethylation | 2.114273e-3 |
GO:0035572 | N-terminal peptidyl-serine dimethylation | 2.114273e-3 |
GO:0018012 | N-terminal peptidyl-alanine trimethylation | 2.114273e-3 |
GO:0018016 | N-terminal peptidyl-proline dimethylation | 2.114273e-3 |
GO:0071044 | histone mRNA catabolic process | 2.154547e-3 |
GO:0010821 | regulation of mitochondrion organization | 2.158723e-3 |
GO:0070428 | regulation of nucleotide-binding oligomerization domain containing 1 signaling pathway | 2.231738e-3 |
GO:0070432 | regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway | 2.231738e-3 |
GO:0090076 | relaxation of skeletal muscle | 2.231738e-3 |
GO:0051901 | positive regulation of mitochondrial depolarization | 2.231738e-3 |
GO:0032470 | elevation of endoplasmic reticulum calcium ion concentration | 2.231738e-3 |
GO:0034140 | negative regulation of toll-like receptor 3 signaling pathway | 2.231738e-3 |
GO:0010724 | regulation of definitive erythrocyte differentiation | 2.255162e-3 |
GO:0006370 | mRNA capping | 2.255162e-3 |
GO:0070972 | protein localization in endoplasmic reticulum | 2.277503e-3 |
GO:0033363 | secretory granule organization | 2.295782e-3 |
GO:0051252 | regulation of RNA metabolic process | 2.312993e-3 |
GO:0072189 | ureter development | 2.336821e-3 |
GO:0048642 | negative regulation of skeletal muscle tissue development | 2.336821e-3 |
GO:0070171 | negative regulation of tooth mineralization | 2.373541e-3 |
GO:0001892 | embryonic placenta development | 2.388252e-3 |
GO:0051220 | cytoplasmic sequestering of protein | 2.397021e-3 |
GO:0042930 | enterobactin transport | 2.409780e-3 |
GO:0046173 | polyol biosynthetic process | 2.494379e-3 |
GO:0061154 | endothelial tube morphogenesis | 2.496969e-3 |
GO:0061047 | positive regulation of branching involved in lung morphogenesis | 2.496969e-3 |
GO:0002043 | blood vessel endothelial cell proliferation involved in sprouting angiogenesis | 2.496969e-3 |
GO:0010452 | histone H3-K36 methylation | 2.512908e-3 |
GO:0060706 | cell differentiation involved in embryonic placenta development | 2.551326e-3 |
GO:0045843 | negative regulation of striated muscle tissue development | 2.719119e-3 |
GO:0000079 | regulation of cyclin-dependent protein kinase activity | 2.811121e-3 |
GO:0072273 | metanephric nephron morphogenesis | 2.831452e-3 |
GO:0035907 | dorsal aorta development | 2.843554e-3 |
GO:0010985 | negative regulation of lipoprotein particle clearance | 2.857871e-3 |
GO:0016571 | histone methylation | 2.858144e-3 |
GO:0015695 | organic cation transport | 2.883081e-3 |
GO:0072074 | kidney mesenchyme development | 2.891613e-3 |
GO:0031060 | regulation of histone methylation | 2.895752e-3 |
GO:0009225 | nucleotide-sugar metabolic process | 2.895752e-3 |
GO:0010862 | positive regulation of pathway-restricted SMAD protein phosphorylation | 2.895752e-3 |
GO:0032057 | negative regulation of translational initiation in response to stress | 2.901177e-3 |
GO:0001996 | positive regulation of heart rate by epinephrine-norepinephrine | 2.935041e-3 |
GO:0006658 | phosphatidylserine metabolic process | 2.951788e-3 |
GO:0030826 | regulation of cGMP biosynthetic process | 2.955013e-3 |
GO:0021666 | rhombomere 5 formation | 2.990383e-3 |
GO:0021660 | rhombomere 3 formation | 2.990383e-3 |
GO:0061156 | pulmonary artery morphogenesis | 3.058583e-3 |
GO:0045116 | protein neddylation | 3.058583e-3 |
GO:0006650 | glycerophospholipid metabolic process | 3.074560e-3 |
GO:0060192 | negative regulation of lipase activity | 3.326235e-3 |
GO:0051005 | negative regulation of lipoprotein lipase activity | 3.388054e-3 |
GO:0007052 | mitotic spindle organization | 3.388054e-3 |
GO:0034382 | chylomicron remnant clearance | 3.388054e-3 |
GO:0001710 | mesodermal cell fate commitment | 3.409046e-3 |
GO:0002507 | tolerance induction | 3.436704e-3 |
GO:0006479 | protein methylation | 3.447601e-3 |
GO:2000348 | regulation of CD40 signaling pathway | 3.527780e-3 |
GO:0048554 | positive regulation of metalloenzyme activity | 3.534209e-3 |
GO:0060338 | regulation of type I interferon-mediated signaling pathway | 3.544501e-3 |
GO:0051013 | microtubule severing | 3.559031e-3 |
GO:2000299 | negative regulation of Rho-dependent protein serine/threonine kinase activity | 3.564859e-3 |
GO:0001539 | ciliary or flagellar motility | 3.681409e-3 |
GO:0006355 | regulation of transcription, DNA-dependent | 3.775313e-3 |
GO:0070925 | organelle assembly | 3.780276e-3 |
GO:0001702 | gastrulation with mouth forming second | 3.808864e-3 |
GO:0072179 | nephric duct formation | 3.874597e-3 |
GO:0002839 | positive regulation of immune response to tumor cell | 3.897287e-3 |
GO:0071544 | diphosphoinositol polyphosphate catabolic process | 3.904751e-3 |
GO:0038027 | apolipoprotein A-I-mediated signaling pathway | 3.904751e-3 |
GO:0006497 | protein lipidation | 3.955500e-3 |
GO:0072488 | ammonium transmembrane transport | 4.064043e-3 |
GO:0072300 | positive regulation of metanephric glomerulus development | 4.064043e-3 |
GO:0043412 | macromolecule modification | 4.093099e-3 |
GO:0021783 | preganglionic parasympathetic nervous system development | 4.128454e-3 |
GO:0021658 | rhombomere 3 morphogenesis | 4.200811e-3 |
GO:0032968 | positive regulation of transcription elongation from RNA polymerase II promoter | 4.200811e-3 |
GO:0018342 | protein prenylation | 4.200811e-3 |
GO:0051900 | regulation of mitochondrial depolarization | 4.228751e-3 |
GO:0001523 | retinoid metabolic process | 4.264338e-3 |
GO:0031668 | cellular response to extracellular stimulus | 4.278926e-3 |
GO:0002315 | marginal zone B cell differentiation | 4.365839e-3 |
GO:0002837 | regulation of immune response to tumor cell | 4.370803e-3 |
GO:0051568 | histone H3-K4 methylation | 4.415434e-3 |
GO:0002312 | B cell activation involved in immune response | 4.451702e-3 |
GO:0051055 | negative regulation of lipid biosynthetic process | 4.552239e-3 |
GO:0003130 | BMP signaling pathway involved in heart induction | 4.557155e-3 |
GO:0006474 | N-terminal protein amino acid acetylation | 4.635296e-3 |
GO:0033539 | fatty acid beta-oxidation using acyl-CoA dehydrogenase | 4.651862e-3 |
GO:0010976 | positive regulation of neuron projection development | 4.653160e-3 |
GO:0021545 | cranial nerve development | 4.738946e-3 |
GO:0001843 | neural tube closure | 4.763146e-3 |
GO:0044238 | primary metabolic process | 4.812514e-3 |
GO:0031448 | positive regulation of fast-twitch skeletal muscle fiber contraction | 4.839148e-3 |
GO:0001997 | positive regulation of the force of heart contraction by epinephrine-norepinephrine | 4.839148e-3 |
GO:0006767 | water-soluble vitamin metabolic process | 4.887167e-3 |
GO:0048635 | negative regulation of muscle organ development | 4.912326e-3 |
GO:0019673 | GDP-mannose metabolic process | 4.924127e-3 |
GO:0035912 | dorsal aorta morphogenesis | 5.119357e-3 |
GO:0021914 | negative regulation of smoothened signaling pathway involved in ventral spinal cord patterning | 5.119357e-3 |
GO:0030038 | contractile actin filament bundle assembly | 5.119357e-3 |
GO:0045844 | positive regulation of striated muscle tissue development | 5.240934e-3 |
GO:0002860 | positive regulation of natural killer cell mediated cytotoxicity directed against tumor cell target | 5.258115e-3 |
GO:0006911 | phagocytosis, engulfment | 5.260877e-3 |
GO:0090280 | positive regulation of calcium ion import | 5.301493e-3 |
GO:0021675 | nerve development | 5.485030e-3 |
GO:0065001 | specification of axis polarity | 5.526611e-3 |
GO:0006068 | ethanol catabolic process | 5.526611e-3 |
GO:0071549 | cellular response to dexamethasone stimulus | 5.570094e-3 |
GO:0061077 | chaperone-mediated protein folding | 5.599918e-3 |
GO:0042268 | regulation of cytolysis | 5.734787e-3 |
GO:0031444 | slow-twitch skeletal muscle fiber contraction | 5.734787e-3 |
GO:0002833 | positive regulation of response to biotic stimulus | 5.764531e-3 |
GO:0072289 | metanephric nephron tubule formation | 5.805151e-3 |
GO:0010770 | positive regulation of cell morphogenesis involved in differentiation | 5.860929e-3 |
GO:0010984 | regulation of lipoprotein particle clearance | 5.898107e-3 |
GO:0031669 | cellular response to nutrient levels | 5.921530e-3 |
GO:0043124 | negative regulation of I-kappaB kinase/NF-kappaB cascade | 5.977951e-3 |
GO:0045062 | extrathymic T cell selection | 6.016801e-3 |
GO:0060231 | mesenchymal to epithelial transition | 6.082625e-3 |
GO:0046486 | glycerolipid metabolic process | 6.164848e-3 |
GO:0002858 | regulation of natural killer cell mediated cytotoxicity directed against tumor cell target | 6.277969e-3 |
GO:0060770 | negative regulation of epithelial cell proliferation involved in prostate gland development | 6.353137e-3 |
GO:0042596 | fear response | 6.400949e-3 |
GO:0051085 | chaperone mediated protein folding requiring cofactor | 6.403458e-3 |
GO:0072012 | glomerulus vasculature development | 6.414852e-3 |
GO:0010757 | negative regulation of plasminogen activation | 6.468120e-3 |
GO:0000492 | box C/D snoRNP assembly | 6.563121e-3 |
GO:0043201 | response to leucine | 6.632884e-3 |
GO:0072298 | regulation of metanephric glomerulus development | 6.928110e-3 |
GO:0032740 | positive regulation of interleukin-17 production | 6.928110e-3 |
GO:0002377 | immunoglobulin production | 6.941603e-3 |
GO:0018960 | 4-nitrophenol metabolic process | 6.992808e-3 |
GO:0046360 | 2-oxobutyrate biosynthetic process | 6.992808e-3 |
GO:0046635 | positive regulation of alpha-beta T cell activation | 7.016472e-3 |
GO:0051103 | DNA ligation involved in DNA repair | 7.141739e-3 |
GO:0015696 | ammonium transport | 7.141739e-3 |
GO:0034115 | negative regulation of heterotypic cell-cell adhesion | 7.141739e-3 |
GO:0010595 | positive regulation of endothelial cell migration | 7.144983e-3 |
GO:0031330 | negative regulation of cellular catabolic process | 7.162241e-3 |
GO:0060606 | tube closure | 7.395896e-3 |
GO:0090009 | primitive streak formation | 7.577370e-3 |
GO:0045736 | negative regulation of cyclin-dependent protein kinase activity | 7.592132e-3 |
GO:0072040 | negative regulation of mesenchymal stem cell apoptosis involved in nephron morphogenesis | 7.641303e-3 |
GO:0000239 | pachytene | 7.659996e-3 |
GO:0006067 | ethanol metabolic process | 7.885262e-3 |
GO:0051572 | negative regulation of histone H3-K4 methylation | 7.885262e-3 |
GO:0061181 | regulation of chondrocyte development | 7.885262e-3 |
GO:0043558 | regulation of translational initiation in response to stress | 7.885262e-3 |
GO:0033979 | box H/ACA snoRNA metabolic process | 7.944560e-3 |
GO:0071346 | cellular response to interferon-gamma | 7.980909e-3 |
GO:0030178 | negative regulation of Wnt receptor signaling pathway | 7.996367e-3 |
GO:0072303 | positive regulation of glomerular metanephric mesangial cell proliferation | 8.252874e-3 |
GO:0002040 | sprouting angiogenesis | 8.316857e-3 |
GO:0010332 | response to gamma radiation | 8.333139e-3 |
GO:0001662 | behavioral fear response | 8.415209e-3 |
GO:0032369 | negative regulation of lipid transport | 8.442895e-3 |
GO:0032471 | reduction of endoplasmic reticulum calcium ion concentration | 8.567989e-3 |
GO:0032365 | intracellular lipid transport | 8.567989e-3 |
GO:0022614 | membrane to membrane docking | 8.567989e-3 |
GO:0045109 | intermediate filament organization | 8.578844e-3 |
GO:0009452 | RNA capping | 8.595665e-3 |
GO:0071385 | cellular response to glucocorticoid stimulus | 8.619029e-3 |
GO:0072202 | cell differentiation involved in metanephros development | 8.705276e-3 |
GO:0048486 | parasympathetic nervous system development | 8.730607e-3 |
GO:0090307 | spindle assembly involved in mitosis | 8.748618e-3 |
GO:0070389 | chaperone cofactor-dependent protein refolding | 8.802749e-3 |
GO:0014020 | primary neural tube formation | 8.860170e-3 |
GO:0045778 | positive regulation of ossification | 8.864944e-3 |
GO:0043543 | protein acylation | 9.056053e-3 |
GO:0002209 | behavioral defense response | 9.101685e-3 |
GO:0006513 | protein monoubiquitination | 9.101685e-3 |
GO:0051253 | negative regulation of RNA metabolic process | 9.118159e-3 |
GO:0072044 | collecting duct development | 9.209635e-3 |
GO:0006720 | isoprenoid metabolic process | 9.240770e-3 |
GO:0048389 | intermediate mesoderm development | 9.292731e-3 |
GO:0072098 | anterior/posterior pattern specification involved in kidney development | 9.292731e-3 |
GO:0009115 | xanthine catabolic process | 9.292731e-3 |
GO:0006172 | ADP biosynthetic process | 9.292731e-3 |
GO:0006527 | arginine catabolic process | 9.292731e-3 |
GO:0007412 | axon target recognition | 9.292731e-3 |
GO:0046633 | alpha-beta T cell proliferation | 9.357314e-3 |
GO:0030828 | positive regulation of cGMP biosynthetic process | 9.612545e-3 |
GO:0015893 | drug transport | 9.770216e-3 |
GO:0035966 | response to topologically incorrect protein | 9.828303e-3 |
GO:0044237 | cellular metabolic process | 9.947379e-3 |
GO:0070602 | regulation of centromeric sister chromatid cohesion | 9.966141e-3 |
GO:0009267 | cellular response to starvation | 1.001238e-2 |
GO:2000345 | regulation of hepatocyte proliferation | 1.020031e-2 |
GO:0032819 | positive regulation of natural killer cell proliferation | 1.020031e-2 |
GO:0030237 | female sex determination | 1.020404e-2 |
GO:0060762 | regulation of branching involved in mammary gland duct morphogenesis | 1.027508e-2 |
GO:0070509 | calcium ion import | 1.027508e-2 |
GO:0070170 | regulation of tooth mineralization | 1.067544e-2 |
GO:0090193 | positive regulation of glomerulus development | 1.071447e-2 |
GO:0060449 | bud elongation involved in lung branching | 1.071447e-2 |
GO:0030521 | androgen receptor signaling pathway | 1.079261e-2 |
GO:0051303 | establishment of chromosome localization | 1.081589e-2 |
GO:0006297 | nucleotide-excision repair, DNA gap filling | 1.086391e-2 |
GO:0072215 | regulation of metanephros development | 1.097063e-2 |
GO:0090200 | positive regulation of release of cytochrome c from mitochondria | 1.106836e-2 |
GO:0006446 | regulation of translational initiation | 1.107922e-2 |
GO:0060602 | branch elongation of an epithelium | 1.108425e-2 |
GO:0072124 | regulation of glomerular mesangial cell proliferation | 1.109912e-2 |
GO:0034139 | regulation of toll-like receptor 3 signaling pathway | 1.109912e-2 |
GO:0003057 | regulation of the force of heart contraction by chemical signal | 1.109912e-2 |
GO:0033233 | regulation of protein sumoylation | 1.109912e-2 |
GO:0050995 | negative regulation of lipid catabolic process | 1.110763e-2 |
GO:0001890 | placenta development | 1.121044e-2 |
GO:0008637 | apoptotic mitochondrial changes | 1.139038e-2 |
GO:0010822 | positive regulation of mitochondrion organization | 1.179955e-2 |
GO:0072190 | ureter urothelium development | 1.190524e-2 |
GO:0016540 | protein autoprocessing | 1.190524e-2 |
GO:0070634 | transepithelial ammonium transport | 1.190524e-2 |
GO:0051570 | regulation of histone H3-K9 methylation | 1.196488e-2 |
GO:0003321 | positive regulation of blood pressure by epinephrine-norepinephrine | 1.230833e-2 |
GO:0006498 | N-terminal protein lipidation | 1.243056e-2 |
GO:0001844 | protein insertion into mitochondrial membrane involved in induction of apoptosis | 1.260703e-2 |
GO:0033088 | negative regulation of immature T cell proliferation in thymus | 1.260703e-2 |
GO:0048599 | oocyte development | 1.263278e-2 |
GO:0060675 | ureteric bud morphogenesis | 1.273014e-2 |
GO:0070613 | regulation of protein processing | 1.281230e-2 |
GO:0003254 | regulation of membrane depolarization | 1.285898e-2 |
GO:0009063 | cellular amino acid catabolic process | 1.305764e-2 |
GO:0031442 | positive regulation of mRNA 3'-end processing | 1.307282e-2 |
GO:0006620 | posttranslational protein targeting to membrane | 1.307282e-2 |